Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironmentKansy, Benjamin A and Lin, Yan and Ding, Fei and Gibson, Sandra Poveda and Jie, Hyun-Bae and Ferris, Robert L (2015) Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment. Journal for ImmunoTherapy of Cancer, 3 (S2).
Share
Details
MetricsMonthly Views for the past 3 yearsPlum AnalyticsAltmetric.comActions (login required)
|